氨基脲敏感性胺氧化酶与心血管病及糖尿病的研究进展李潮生

sensitivityinhealthypeopleduringtheconsumptionofanoliveoil-richdietJ．JClinEndocrinolMetab20059042297-2300．10BonenAParolinMLSteinbergGＲetal．Triacylglycerolaccumu-lationinhumanobesityandtype2diabetesisassociatedwithincreasedratesofskeletalmusclefattyacidtransportandincreasedsarcolemmalFAT/CD36J．FASEBJ200418101144-1146．11WatanabeKNakazatoYSaikiＲetal．Acrolein-conjugatedlow-densitylipoproteininducesmacrophagefoamcellformationJ．Atherosclerosis2013227151-57．12WilmsenHMCiaraldiTPCarterLetal．Thiazolidinedionesupregulateimpairedfattyaciduptakeinskeletalmuscleoftype2diabeticsubjectsJ．AmJPhysiolEndocrinolMetab20032852E354-E362．13ConnellyMAWilliamsDL．ScavengerreceptorBIascavengerreceptorwithamissiontotransporthighdensitylipoproteinlipidsJ．CurrOpinLipidol2004153287-295．14VanEckMTwiskJHoekstraMetal．Differentialeffectsofscav-engerreceptorBIdeficiencyonlipidmetabolismincellsofthearterialwallandintheliverJ．JBiolChem20032782623699-23705．15LamharziNＲenardCBKramerFetal．Hyperlipidemiainconcertwithhyperglycemiastimulatestheproliferationofmacrophagesinatheroscleroticlesionspotentialroleofglucose-oxidizedLDLJ．Diabetes200453123217-3225．16HubyTDoucetCDachetCetal．KnockdownexpressionandhepaticdeficiencyrevealanatheroprotectiveroleforSＲ-BIinliverandperipheraltissuesJ．JClinInvest2006116102767-2776．17MineoCShaulPW．FunctionsofscavengerreceptorclassBtypeⅠinatherosclerosisJ．CurrOpinLipidol2012235487-493．18SvenssonLCamejoGCabréAetal．FattyacidsmodulatetheeffectofdarglitazoneonmacrophageCD36expressionJ．EurJClinInvest2003336464-471．19KimHHaluzikMGavrilovaOetal．Thiazolidinedionesimproveinsulinsensitivityinadiposetissueandreducethehyperlipidaemiawithoutaffectingthehyperglycaemiainatransgenicmodeloftype2diabetesJ．Diabetologia200447122215-2225．20TanGDFieldingBACurrieJMetal．Theeffectsofrosiglitazoneonfattyacidandtriglyceridemetabolismintype2diabetesJ．Diabetologia200548183-95．21FazioSLintonMF．InterplaybetweenapolipoproteinEandscaven-gerreceptorclassBtypeⅠcontrolscoronaryatherosclerosisandlifespaninthemouseJ．Circulation2005111253349-3351．22ZhangSPicardMHVasileEetal．Diet-inducedocclusivecoro-naryatherosclerosismyocardialinfarctioncardiacdysfunctionandprematuredeathinscavengerreceptorclassBtypeI-deficienthypomorphicapolipoproteinEＲ61miceJ．Circulation2005111253457-3464．23CaoWMMuraoKImachiHetal．Insulin-likegrowthfactor-ireg-ulationofhepaticscavengerreceptorclassBIJ．Endocrinology2004145125540-5547．24SvenssonPAEnglundMCSnckestrandMSetal．ＲegulationandsplicingofscavengerreceptorclassBtypeⅠinhumanmacropha-gesandatheroscleroticplaquesJ．BMCCardiovascDisord2005525．2013-08-192013-12-04辛欣李潮生1△陈军2※1．5240002．518100Ｒ363A1006-2084201413-2317-03doi10．3969/j．issn．1006-2084．2014．13．0062012年广东省社会发展领域科技计划项目课题(20120318093)SSAO。SSAO、。SSAO。SSAO、、。SSAO。TheＲesearchProgressofSemicarbazide-sensitiveAmineOxidasewithCardiovascularDiseaseandDiabetesLIChao-sheng1CHENJun2．1．PostgraduateDepartmentofGuangdongMedicalCollegeZhan-jiang524000China2．CardiovascularDepartmentShenzhenBao'anPeople'sHospitalShenzhen518100ChinaAbstractSemicarbazide-sensitiveamineoxidaseSSAOispresentwidelyinhumanbodyandhasvariousphysiologicalfunctions．Oxidativedeaminationofshort-chainprimaryaminesiscatalyzedbythisenzymetoaffordthecorrespondingaldehydeshydrogenperoxideandammonia．MethylamineandaminoacetonearephysiologicalsubstratesforSSAO．PlasmaSSAOactivityincreasessignificantlyonpatientswithcardiovas-culardiseaseanddiabetes．Toxicaldehydeproductsmaycontributetotheendothelialinjuryofbloodvesselsandoxidativestressthuspromotingatherosclerosisandcomplicationsofdiabeticangiopathy．Thereforepatho-physiologicresearchofSSAOwithcardiovasculardiseaseanddiabeteshasbecomeanewresearchhotspot．KeywordsSemicarbazide-sensitiveamineoxidaseInhibitorsAtherosclerosisDiabetessemicarbazide-sensitiveamineoxidaseSSAO、hydrogenperoxideH2O2。、、、、、SSAO1-3SSAO、。1SSAOmonoamineoxidaseMAO-AMAO-B。、SSAO、、SSAO1vascularadhesionpro-tein-1VAP-14。SSAOMAOMAOSSAO5。·7132·201472013MedicalＲecapitulateJul．2014Vol．20No．132SSAO2．1SSAOSSAOD2、D3、D46。SSAOSSAO6SSAO7。SSAO--SSAO、。SSAO180×1031molSSAO2mol、1mol16-SSAO8。2．2SSAOSSAO1717q21SSAOAOC1、AOC2、AOC3、AOC4。AOC1、、9AOC2SSAO10AOC3SSAO/VAP-1、、、、11。AOC422512。SSAOSSAOSSAOSSAOSSAO。SSAOSSAO80%5。2．3SSAOSSAO、H2O2。SSAOSSAOMAO、。、SSAO、H2O213。SSAO。3SSAOVAP-1SSAO、14。SSAO/VAP-1、H2O2、。SSAO、-DNA。H2O2。SSAOH2O2、advancedglycatedendproductsAGEsAGEs15。、16VAP-1、、15。17SSAO/VAP-1SSAO/VAP-118。SSAO/VAP-1、、。、、SSAO。SSAO/VAP-1/40%SSAO/VAP-1/19。Yang20/SDSSAO3minSSAOSSAO-。Marinho21SSAOSSAO、、。Li226612VAP-15．8395%CI1．17～28．97。VAP-12。4SSAO。、、。SSAOSSAO、。SSAO、。Almulki23VAP-1。Yoshikawa242VAP-1SSAO/VAP-1AGEsSSAO、、25。Valente3SSAO/VAP-1AGEs、AGEs、1SSAO/VAP-1。Li2611530minSSAO/VAP-12hSSAO/VAP-1、AGEs、SSAO/VAP-1。SSAO/VAP-1、、AGEs、。5SSAOSSAO、。SSAOSSAO·8132·201472013MedicalＲecapitulateJul．2014Vol．20No．13、、AGEs。SSAO27。SSAO。semicarbazide、aminogua-nidineE-2-4--3-MDL72974A、E-2-34--3-MDL72145。2-。SSAO、。、、SSAOSSAO22228。6、、SSAO。SSAO/VAP-1、SSAO/VAP-1。SSAO。SSAOSSAO、。1NodaKNakaoSZandiSetal．Vascularadhesionprotein-1regu-latesleukocytetransmigrationrateintheretinaduringdiabetesJ．ExpE